Literature DB >> 10781349

The optimal management of cardioversion of atrial fibrillation or flutter: still a 'stunning' problem.

C Stellbrink, P Hanrath.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10781349     DOI: 10.1053/euhj.1999.2051

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  1 in total

1.  Low molecular weight heparin (parnaparin) for cardioembolic events prevention in patients with atrial fibrillation undergoing elective electrical cardioversion: a prospective cohort study.

Authors:  Giulia Angeloni; Silvia Alberti; Enrico Romagnoli; Alberto Banzato; Marco Formichi; Umberto Cucchini; Vittorio Pengo
Journal:  Intern Emerg Med       Date:  2010-11-17       Impact factor: 3.397

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.